Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Marsoni

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|March 25, 2015
A lesson from vorinostat in pleural mesotheliomaMarina Chiara Garassino, Silvia Marsoni
Epigenetics|May 20, 2008
A work in progress: the clinical development of histone deacetylase inhibitorsSilvia Marsoni, Giovanna Damia, Gabriella Camboni
JAMA Oncology|October 20, 2017
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
JAMA Oncology|August 16, 2019
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2011
Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coinMarina Chiara Garassino, Silvia Marsoni, Irene Floriani
Cancer Cell|August 29, 2020
Breaking Barriers in HER2+ CancersSalvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
Nature Reviews. Clinical Oncology|March 3, 2017
Integrating liquid biopsies into the management of cancerGiulia Siravegna, Silvia Marsoni, Salvatore Siena, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
New omics information for clinical trial utility in the primary settingGiovanna Damia, Massimo Broggini, Silvia Marsoni, et al.
Molecular Oncology|December 7, 2018
Early-onset colorectal cancer in young individualsGianluca Mauri, Andrea Sartore-Bianchi, Antonio-Giampiero Russo, et al.
JAMA Oncology|April 24, 2020
Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and LapatinibAndrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|March 25, 2015
A lesson from vorinostat in pleural mesotheliomaMarina Chiara Garassino, Silvia Marsoni
Epigenetics|May 20, 2008
A work in progress: the clinical development of histone deacetylase inhibitorsSilvia Marsoni, Giovanna Damia, Gabriella Camboni
JAMA Oncology|October 20, 2017
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
JAMA Oncology|August 16, 2019
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Silvia Marsoni, Salvatore Siena
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2011
Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coinMarina Chiara Garassino, Silvia Marsoni, Irene Floriani
Cancer Cell|August 29, 2020
Breaking Barriers in HER2+ CancersSalvatore Siena, Silvia Marsoni, Andrea Sartore-Bianchi
Nature Reviews. Clinical Oncology|March 3, 2017
Integrating liquid biopsies into the management of cancerGiulia Siravegna, Silvia Marsoni, Salvatore Siena, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
New omics information for clinical trial utility in the primary settingGiovanna Damia, Massimo Broggini, Silvia Marsoni, et al.
Molecular Oncology|December 7, 2018
Early-onset colorectal cancer in young individualsGianluca Mauri, Andrea Sartore-Bianchi, Antonio-Giampiero Russo, et al.
JAMA Oncology|April 24, 2020
Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and LapatinibAndrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, et al.
Pageof 9